Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry

INTRODUCTION: Tumor necrosis factor inhibitors (TNFis) have shown efficacy for the treatment of ankylosing spondylitis (AS). However, many patients may discontinue or switch TNFis due to lack of effect or adverse events. As biologics with alternative mechanisms of action become available for the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip J., van der Heijde, Désirée, Karki, Chitra, Liu, Mei, Park, Yujin, Greenberg, Jeffrey D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251840/
https://www.ncbi.nlm.nih.gov/pubmed/30353387
http://dx.doi.org/10.1007/s40744-018-0129-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251840/
https://www.ncbi.nlm.nih.gov/pubmed/30353387
http://dx.doi.org/10.1007/s40744-018-0129-z

Ejemplares similares